{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:45:23Z","timestamp":1782139523919,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T00:00:00Z","timestamp":1519171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"The Project of Development and Reform Commission of Hunan Province in China","award":["Xiang Cai Qi Zhi (2015)83"],"award-info":[{"award-number":["Xiang Cai Qi Zhi (2015)83"]}]},{"name":"The Natural Science Foundation of Hunan Province in China","award":["2016JJ2167"],"award-info":[{"award-number":["2016JJ2167"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40272-018-0284-2","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T11:31:16Z","timestamp":1519385476000},"page":"285-290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of Levocarnitine on the Therapeutic Efficacy of Conventional Therapy in Children with Dilated Cardiomyopathy: Results of a Randomized Trial in 29 Children"],"prefix":"10.1007","volume":"20","author":[{"given":"Yuwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runmei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7120-0654","authenticated-orcid":false,"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,21]]},"reference":[{"key":"284_CR1","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891\u2013975.","journal-title":"Eur J Heart Fail"},{"key":"284_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1743-7075-7-30","volume":"7","author":"JL Flanagan","year":"2010","unstructured":"Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q. Role of carnitine in disease. Nutr Metab (Lond). 2010;7:30.","journal-title":"Nutr Metab (Lond)"},{"key":"284_CR3","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807\u201316.","journal-title":"Circulation"},{"key":"284_CR4","first-page":"258","volume-title":"Handbook of pediatric cardiovascular","author":"C Wang","year":"2002","unstructured":"Wang C. Handbook of pediatric cardiovascular. Beijing: People\u2019s Military Medical Press; 2002. p. 258\u201366."},{"key":"284_CR5","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","volume":"296","author":"JA Towbin","year":"2006","unstructured":"Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296:1867\u201376.","journal-title":"JAMA"},{"key":"284_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000455181","volume":"137","author":"R Yu","year":"2017","unstructured":"Yu R, Liu L, Chen C, Shen JM. Exome sequencing identifies a novel DES mutation (R227C) in a Chinese dilated cardiomyopathy family. Cardiology. 2017;137:78\u201382.","journal-title":"Cardiology"},{"key":"284_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2350-15-77","volume":"15","author":"M Zhang","year":"2014","unstructured":"Zhang M, Chen J, Si D, Zheng Y, Jiao H, Feng Z, et al. Whole exome sequencing identifies a novel EMD mutation in a Chinese family with\u00a0dilated cardiomyopathy. BMC Med Genet. 2014;15:77.","journal-title":"BMC Med Genet"},{"key":"284_CR8","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1161\/CIRCULATIONAHA.113.002767","volume":"128","author":"PM Alexander","year":"2013","unstructured":"Alexander PM, Daubeney PE, Nugent AW, Lee KJ, Turner C, Colan SD, et al. Long-term outcomes of\u00a0dilated cardiomyopathy\u00a0diagnosed during\u00a0childhood: results from a national population-based study of childhood cardiomyopathy. Circulation. 2013;128:2039\u201346.","journal-title":"Circulation"},{"key":"284_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2165\/00003495-200262050-00001","volume":"62","author":"R Rocha","year":"2002","unstructured":"Rocha R, Williams GH. Rationale for the use of aldosterone antagonists in congestive heat failure. Drugs. 2002;62:723\u201331.","journal-title":"Drugs"},{"key":"284_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1056\/NEJM199209033271003","volume":"327","author":"The SOLVD Investigators","year":"1992","unstructured":"The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685\u201391.","journal-title":"N Engl J Med"},{"key":"284_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijcard.2015.07.007","volume":"198","author":"M Chen","year":"2015","unstructured":"Chen M, Yu L, Sheng X, Liu Q, Jiang H, Zhou S. Cardiac autonomic tone modulators: promising feasible options for heart failure with hyper-sympathetic activity. Int J Cardiol. 2015;198:185\u20136.","journal-title":"Int J Cardiol"},{"key":"284_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jacc.2007.03.048","volume":"50","author":"JN Kirkpatrick","year":"2007","unstructured":"Kirkpatrick JN, Vannan MA, Narula J, Lang RM. Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol. 2007;50:381\u201396.","journal-title":"J Am Coll Cardiol"},{"key":"284_CR13","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/pd.4391","volume":"34","author":"J Zhou","year":"2014","unstructured":"Zhou J, Zhou Q, Zhang M, Zeng S, Peng Q, Tian L. Echocardiographic follow-up and pregnancy outcome of fetuses with cardiac asymmetry at 18\u201322\u00a0weeks of gestation. Prenat Diagn. 2014;34:900\u20137.","journal-title":"Prenat Diagn"},{"key":"284_CR14","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP, Dahlstr\u00f6m U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, et al. EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2013;15:808\u201317.","journal-title":"Eur J Heart Fail"},{"key":"284_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.cardiores.2003.11.014","volume":"61","author":"M Bilsen van","year":"2004","unstructured":"van Bilsen M, Smeets PJ, Gilde AJ, van der Vusse GJ. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res. 2004;61:218\u201326.","journal-title":"Cardiovasc Res"},{"key":"284_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejphar.2013.03.025","volume":"709","author":"AA Strilakou","year":"2013","unstructured":"Strilakou AA, Lazaris AC, Perelas AI, Mourouzis IS, Douzis ICh, Karkalousos PL, et al. Heart dysfunction induced by choline-deficiency in adult rats: the protective role of L-carnitine. Eur J Pharmacol. 2013;709:20\u20137.","journal-title":"Eur J Pharmacol"},{"key":"284_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.trsl.2012.10.006","volume":"161","author":"SM Marcovina","year":"2013","unstructured":"Marcovina SM, Sirtori C, Peracino A, Gheorghiade M, Borum P, Remuzzi G, et al. Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine. Transl Res. 2013;161:73\u201384.","journal-title":"Transl Res"},{"key":"284_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s00380-014-0479-6","volume":"30","author":"M Miyata","year":"2015","unstructured":"Miyata M, Yoshihisa A, Yamauchi H, Owada T, Sato T, Suzuki S, et al. Impact of sleep-disordered breathing on myocardial damage and metabolism in patients with chronic heart failure. Heart Vessels. 2015;30:318\u201324.","journal-title":"Heart Vessels"},{"key":"284_CR19","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1097\/HJH.0b013e3283569c5a","volume":"30","author":"Y Omori","year":"2012","unstructured":"Omori Y, Ohtani T, Sakata Y, Mano T, Takeda Y, Tamaki S, et al. L-Carnitine prevents the development of ventricular fibrosis and heart failure with preserved ejection fraction in hypertensive heart disease. J Hypertens. 2012;30:1834\u201344.","journal-title":"J Hypertens"},{"key":"284_CR20","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0735-1097(02)02160-5","volume":"40","author":"M Beer","year":"2002","unstructured":"Beer M, Seyfarth T, Sandstede J, Landsch\u00fctz W, Lipke C, K\u00f6stler H, et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic reasonance spectroscopy. J Am Coll Cardiol. 2002;40:1267\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"284_CR21","volume-title":"Experimental study of levocarnitine on cardiomyocyte apoptosis","author":"C Mao","year":"2014","unstructured":"Mao C. Experimental study of levocarnitine on cardiomyocyte apoptosis. Changchun: Jilin University; 2014."},{"key":"284_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00726-007-0598-9","volume":"35","author":"H Xie","year":"2008","unstructured":"Xie H, Tang SY, Li H, Luo XH, Yuan LQ, Wang D, et al. L-carnitine protects against apoptosis of murine MC3T3-E1 osteoblastic cells. Amino Acids. 2008;35:419\u201323.","journal-title":"Amino Acids"},{"key":"284_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2174\/1389201033489829","volume":"4","author":"A Evangeliou","year":"2003","unstructured":"Evangeliou A, Vlassopoulos D. Carnitine metabolism and deficit\u2013when supplementation is necessary? Curr Pharm Biotechnol. 2003;4:211\u20139.","journal-title":"Curr Pharm Biotechnol"},{"key":"284_CR24","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.bcp.2012.12.021","volume":"85","author":"S Zambrano","year":"2013","unstructured":"Zambrano S, Blanca AJ, Ruiz-Armenta MV, Miguel-Carrasco JL, Ar\u00e9valo M, V\u00e1zquez MJ, et al. L-Carnitine protects against arterial hypertension-related cardiac fibrosis through modulation of PPAR-\u03b3 expression. Biochem Pharmacol. 2013;85:937\u201344.","journal-title":"Biochem Pharmacol"},{"key":"284_CR25","first-page":"368","volume":"81","author":"VM Azevedo","year":"2005","unstructured":"Azevedo VM, Albanesi Filho FM, Santos MA, Castier MB, Cunha MO. The role of L-carnitine in nutritional status and echocardiographic parameters in idiopathic dilated cardiomyopathy in children. J Pediatr (Rio J). 2005;81:368\u201372.","journal-title":"J Pediatr (Rio J)"},{"key":"284_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10557-007-6056-9","volume":"21","author":"YZ Xue","year":"2007","unstructured":"Xue YZ, Wang LX, Liu HZ, Qi XW, Wang XH, Ren HZ. L-carnitine as an adjunct therapy to percutaneous coronary intervention for non-ST elevationmyocardial infarction. Cardiovasc Drugs Ther. 2007;21:445\u20138.","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-018-0284-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-018-0284-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-018-0284-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T19:37:40Z","timestamp":1550691460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-018-0284-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,21]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["284"],"URL":"https:\/\/doi.org\/10.1007\/s40272-018-0284-2","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,21]]},"assertion":[{"value":"21 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work is supported by grants from The Project of Development and Reform Commission of Hunan Province in China [Xiang Cai Qi Zhi (2015)83] and The Natural Science Foundation of Hunan Province in China (2016JJ2167).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Yuwen Wang, Yi Xu, Runmei Zou, Lijia Wu, Ping Liu, Hong Yang, Zhenwu Xie and Cheng Wang declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}